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Available online 14 October 2015AbstractOral squamous cell carcinoma (OSCC) is a characteristic aggressiv e tumor representing a significant public health threat all
over the world. Up to 50e60% of solid tumors may exhibit hypoxic tissue areas that are heterogeneously distributed within the
tumor stroma. Hypoxia inducible factor-1a (HIF-1a) is a central regulator in the adaptive cellular response to hypoxia; however its
role is still uncovered. Vascular endothelial growth factor (VEGF) is an important molecule playing crucial role not only in
inflammation, but also in angiogenesis and thus tumor growth and progression. So, the aim of this work is to investigate the
expression of HIF-1a and VEGF in OSCC and correlate their expressions with clinical and histopathological features of OSCC. In
this work, tissue specimens from a total of 45 cases with OSCC were stained immunohistochemically with HIF-1a and VEGF
antibodies and examined microscopically.
The results of this study revealed that HIF-1a and VEGF expressions appeared to be significantly positive and directly related to
histopathological grades, lymph node (LN) status as well as clinical stages of OSCC. Moreover, HIF-1a expression was signifi-
cantly correlated to angiogenic activity measured by VEGF immunostaining. Thus, it was concluded that HIF-1a and VEGF
expressions were up-regulated with increased malignancy and can be used as predictive markers of tumor behavior.
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Worldwide, oral cancer (OC) is a public health
problem, representing the sixth most common malig-
nant neoplasm. Oral squamous cell carcinoma (OSCC)
is considered the most frequent of all oral neoplasms
representing about 95% of these neoplasms [1].
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changes in tumor microenvironment (TME) that lead
to the production of new components and/or upregu-
lation of its molecules that play significant roles in
tumor progression. These changes that occur in OSCC
progressively increase the ability of transformed cells
to proliferate and invade. The heterogeneity of these
changes explains why tumors at the same clinical stage
and localization often show significant differences in
their clinical outcomes and treatment responses [2,3].
Hypoxia is one of the most common changes that
occur in the TME and it is a common characteristic of
human solid tumors, and it can drive malignant cells to
undergo adaptive changes that enable them to survive
in oxygen-depleted regions. Hypoxia inducible factor-
1(HIF-1) is a transcription factor composed of two
subunits namely HIF-1a and HIF-1b. HIF-1b is a
constitutively nuclear-located subunit that is found
under all oxygen conditions. However, HIF-1a is a
highly regulated subunit that is extremely labile in
normoxia with a half-life of less than 5 min. The rapid
and continuous degradation of HIF-1a is effectively
blocked if oxygen availability is reduced. This permits
dimerization with HIF-1b to form the active HIF-1
complex [4,5].
HIF-1a contains a unique oxygen-dependent
degradation domain (ODDD) that is central to the
oxygen-regulated stability of this protein. Specific
degradation of HIF-1a in normoxia is triggered
through this domain. Therefore, hypoxia increases
HIF-1 levels in cells by strongly stabilizing HIF-1a
through the inhibition of its rapid degradation by the
proteasome [5]. These striking criteria in oxygen
sensitivity & trans-activation ability of HIF-1a make it
the main functional protein of HIF-1 complex [4].
More than 60 genes have been found to be induced by
HIF-1a that are implicated in many different cellular
functions such as cell survival, cell proliferation,
apoptosis, glucose metabolism and angiogenesis [6].
Many studies have shown that the immunohisto-
chemical (IHC) expression of HIF-1a is associated with
a poor prognosis, however others have only shown a
trend for poor prognosis and some have been not been
statistically significant. In three studies, in head and
neck (HN) cancer, OC and non-small cell lung cancer,
HIF-1a expression predicted a good prognosis [7e9].
One of the studies where HIF-1a expression was a
good prognostic factor showed a strong correlation
between HIF-1a and the expression of pro-apoptotic
factors such as caspase-3, Fas, and Fas ligand [9].
In addition to prognosis, HIF-1a expression was also
investigated in some studies on esophageal cancerpatients to predict response to chemo-radiotherapy.
HIF-1a expression predicted a poor treatment response
[5,10].
Liang et al. [11], has reported that HIF-1a over-
expression was correlated significantly with the clin-
ical stage, histopathological grade, lymph node (LN)
metastasis and worse prognosis in patients with OSCC
of the tongue. Furthermore, it was found that HIF-1a
over-expression in combination with deficiency or
mutation of tumor suppressor genes such as von Hipple
Lindu (vHL), p53, and amplification of oncogenes as
Akt and Ras was frequently seen in human cancer and
these genetic alterations have been associated with
tumor growth, invasion and metastasis. Most cancers
over-expressing HIF-1a are associated with increased
mortality [12].
Angiogenesis is also essential for the development
of solid tumors and the survival of their cells. Tumor
cells that are located more than 100 mm away from
blood vessels become hypoxic. If new blood vessels do
not form, tumor clones will be confined within
1e1.5 mm3 diameter. Such clones remain dormant
from months to years before they switch to an angio-
genic phenotype [13]. In the beginning, angiogenesis
develops by incorporating existing host blood vessels;
no solid tumors can probably grow more than 2 mm3
unless they synthesize their own network of new
microvessels. This angiogenic switch is dependent
mainly on hypoxia and oncogenic transformation
which occurs in tumor cells, or in an autocrine growth
factor loop [14].
Vascular endothelial growth factor (VEGF) is
considered a potent angiogenic activator and its asso-
ciate receptor (VEGFR-2). VEGF is a member of
platelet-derived growth factor (PDGF) superfamily of
growth factors that triggers mobility and maturation of
endothelial cells (ECs) towards the hypoxic environ-
ment that allows blood and oxygen to reach hypoxic
cells [15]. It has long been established that ECs of
tumor-associated neovasculature proliferate 20e2000
times more rapidly than ECs of normal tissue [16].
Macluskey et al. [17] and Carlile et al. [18],
observed a significant increase in vascularity during the
transition from normal oral mucosa, through different
degrees of dysplasia, to invasive carcinoma. Several
studies have also reported a close association between
tumor angiogenesis and tumor progression from early
to late OSCC [19,20]. However, conflicting results
were reported relating to HIF-1a and VEGF expres-
sions in HN cancers.
So, the aim of the present work is to investigate the
expression and the distribution patterns of HIF-1a and
Table 1
Clinical findings of OSCC.
Clinical data Range Mean± SD
Age (years) 28e76 54.5 ± 11.18
n (%)
Sex
Male 24 (53.3)
Female 21 (46.7)
Size of primary tumor
<2 cm 13 (28.8)
2e4 cm 16 (35.6)
>4 cm 16 (35.6)
Site of primary tumor
Tongue 17 (37.8)
Buccal mucosa 10 (22.2)
Gingiva 5 (11.1)
Lip 4 (8.9)
Palate 4 (8.9)
Floor of the mouth 3 (6.7)
Alveolar mucosa 2 (4.4)
Lymph node involvement 13 (28.9)
Clinical stage (UICC)
Stage I 13 (28.9)
Stage II 12 (26.7)
Stage III 12 (26.7)
Stage IV 8 (17.7)
Clinical presentation
Exophytic 22 (48.9)
Endophytic 17 (37.8)
Red and/or white lesion 6 (13.3)
Duration
<12 months 20 (44.4)
>12 months 25 (55.6)
Local recurrence 2 (4.4)
Total 45 (100)
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expressions with the clinico-pathological features of
OSCC to clarify their role in the biological behavior of
this tumor.
2. Material and methods
- The present study included 45 cases with OSCC who
were diagnosed and subjected to surgery at Tanta Cancer
Center and Oral and Maxillofacial Surgery Department,
Faculty of Dentistry, Tanta University. Neither pre-
operative chemotherapy nor radiotherapy was per-
formed. Informed consent was obtained from all the
patients examined in this study. Detailed case history and
thorough clinical examination with clinical staging was
performed for each case.
- The fresh tissue specimens of OSCC were fixed in 10%
neutral buffered formalin and routinely processed for
hematoxylin and eosin (H&E), examined under light
microscope and graded histologically.
- For IHC study, the AvidineBiotin Complex (ABC)
technique was used to detect the following reagents:
- Primary antibodies against HIF-1a (Clone: 54/HIF-1a,
Mouse monoclonal, Becton Dickinson (BD) Trans-
duction Laboratories, Franklin Lakes, USA) and
VEGF (Clone: SP6, Rabbit monoclonal, Neomarkers,
Fremont CA, USA). The Avidin Biotin Complex
(ABC) Universal Kit (Neomarkers, Fremont CA, USA)
was used.
- The immunostaining procedure was performed accord-
ing to the manufacturer' instructions. The deparaffinized
sections associated with immunostaining kit were pro-
cessed acting as positive controls whereas negative
controls consisting of tissue sections on which primary
antibody was replaced with non-immune serum was also
performed.
- The sections were evaluated for HIF-1a and VEGF ex-
pressions by assessing the site of staining (nuclear and/or
cytoplasmic). Scoring the IHC positivity was done using
two parameters; staining intensity and percentage of
stained positive cells within 4 different microscopic
fields of the same section at X200 magnification as fol-
lows: Percentage of positive cells: (0) if the tumor cells
showed no reactivity of antigen (1), (Focal) if <30% of
the tumor cells are positive (2), (Partial) if 30e60% of
the tumor cells are positive (3), (Diffuse) if >60% of the
tumor cells are positive. The intensity: 1 ¼ [weak],
2 ¼ [moderate], 3 ¼ [strong].
- Final score for each case was the sum of both intensity and
percentage andwas represented as follows:Negative¼ (0),
Weak¼ (2e3), Moderate¼ (4), Strong¼ (5e6).
- All IHC evaluation was performed by two independent
observers blind to clinical information of the cases and
the average of both observers' scoring was used.
- Statistical analysis was done using Monte Carlo exact
test by SPSS program V.19 and Spearman's rankcorrelation coefficient (rho). The p value for significance
was adopted at P < 0.05.3. Results
3.1. Clinical findings
- All the observed clinical findings of OSCC cases
are showed in Table 1. It was found that the mean
age of the studied cases was 54 years old and the
tongue was the most commonly affected site (17
cases) followed by buccal mucosa (10 cases).
Twenty cases were classified clinically as advanced
stages (Stage III and IV) and 22 cases of OSCC
appeared as exophytic fungating masses with or
without surface ulcerations (Fig. 1A), while 17
cases appeared as endophytic ulcerative lesions
(Fig. 1B). The remaining 6 cases appeared clini-
cally as white and/or red lesions (Fig. 1C). Thir-
teen cases showed LN metastasis and 2 cases
recurred locally.
Fig. 1. Intra-oral photographs are showing:(A) OSCC appears as
exophytic mass at the right buccal mucosa with shallow ulceration.
(B) Deep malignant ulcer of OSCC at the left postero-lateral side of
the tongue. (C) A case of OSCC appears as mixed red and white
lesion at the floor of the mouth.
Fig. 2. Analysis of the relation between histopathologi
S4 H. El-Sayed Mohammed Youssef et al. / Tanta Dental Journal 12 (2015) S1eS143.2. Conventional hematoxylin and eosin staining
(H&E)
- By light microscopic examination, 19 cases out of
the 45 cases of OSCC were diagnosed as well-
differentiated (Grade I) (Fig. 5a), 17 cases were
diagnosed as moderately differentiated (Grade II)
(Fig. 6a) and the remaining 9 cases were poorly
differentiated tumors (Grade III) (Fig. 7a).
- It was observed that 14 out of 25 cases with early
stages of OSCC (Stage I and II) were well-
differentiated histologically and only 3 cases
were poorly differentiated tumors. Five cases of
OSCC out of 20 with advanced clinical stages
(Stage III and IV) were diagnosed as well-
differentiated tumors, while 6 cases were poorly
differentiated (Table 2) (Fig. 2). The clinical stages
showed non-significant correlation to the histo-
pathological grades (p ¼ 0.067, rho ¼ 0.276) (i.e.
the lesser degree of differentiation of the tumor
cells is not essentially associated with more
advanced clinical stage of OSCC).
3.3. Immunohistochemical staining
3.3.1. Correlation of antigen reactivity to the clinical
findings
- Regarding the age of the patients, most cases of
OSCC at the 7th and 8th decades of life showed
high (moderates and strong) HIF-1a and VEGF
reactivities representing 68.7% (11 out of 16 cases)
and 81% (13 cases) for each antigen respectively.
However, all patients at the 3rd and 4th decades of
life (4 cases) showed weak expressions of HIF-1a
and VEGF except one case of them revealed nocal grades and different clinical stages of OSCC.
Fig. 3. Analysis of HIF-1a expression in different clinical stages of OSCC.
Fig. 4. Analysis of VEGF expression in different clinical stages of OSCC.
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showed the highest levels of HIF-1a and VEGF
stainings representing 67% and 35% respectively.
However, the correlation was not significant be-
tween the site of OSCC and expressions of the
studied antigens (Tables 3 and 4).
- HIF-1a immunostaining increased significantly
with advanced clinical stages of OSCC
(p ¼ 0.002), hence 11 out of 20 cases with stage III
and IV showed strong HIF-1a reactivity, while
only 1 case out of 25 with stages I and II showed
marked upregulation of HIF-1a expression (Table
5) (Fig. 3). Similarly, VEGF reactivity was
significantly correlated to clinical stages of OSCC(p ¼ 0.002), since VEGF was weak in 11 cases of
stage I cases. However, 6 cases of stage IV-OSCC
showed strong VEGF reactivity and 2 cases were
moderately-stained with VEGF, while no cases
showed weak VEGF (Table 5) (Fig. 4).
- HIF-1a and VEGF expressions were significantly
correlated to LN involvement (p ¼ 0.001 for each)
as 9 cases out of 13 with LN metastasis (69%)
showed strong staining of both antigens, while
65% of cases (21 out of 32 cases) without any
nodal involvement showed negative or weak HIF-
1a and VEGF immunostainings. Strong HIF-1a
expression was also observed in cases that showed
local recurrence.
Fig. 5. Well-differentiated OSCC (a) Epithelial and keratin pearls invading the connective tissue (H&E, 200), (b) Localized weak cytoplasmic
HIF-1a expression around keratinized area (ABC, 200), (c) Localized weak HIF-1a reactivity at the peripheral cell layer of epithelial pearls
(ABC, 200), (d) Negative HIF-1a immunostaining (ABC, 200), (e) Weak endothelial HIF-1a at the tumor stroma (Red arrows) (ABC, 400),
(f) Localized weak cytoplasmic VEGF immunostaining of tumor nests as well as focal VEGF staining of stromal cells (Blue arrow) (ABC, 200).
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3.3.2.1. Well-differentiated OSCC (grade I, 19 cases)
- HIF-1a immunoreactivity appeared as a localized
or focal granular cytoplasmic and/or nuclear brown
staining of mainly the peripheral malignant cell
layers in the keratin and epithelial pearls. It was
more pronounced around areas of necrosis and
keratinization (Fig. 5b and c). In most cases, HIF-
1a expression appeared more intense in areas away
from the closest blood vessels.
- Cytoplasmic HIF-1a was predominant than nuclear
staining or may appear the only expression pattern
in 12 cases of well-differentiated OSCC (63%)
(Fig. 6b). Almost all of these cases (11 cases) were
clinically classified as stage I and II. HIF-1a
staining was not positive in only one case (Fig. 5d).
HIF-1a expression was also seen in vascular ECs
of the tumor stroma in 9 cases (47%) (Fig. 5e).
- VEGF expression appeared mostly as localized
cytoplasmic brown staining of the tumor cells with
higher intensity at the outer cell layers and lessintense toward the center. In addition, stromal cells
including inflammatory cells, ECs, fibroblasts also
demonstrated cytoplasmic VEGF reactivity espe-
cially those cells at the tumorestroma interface
(Fig. 5f). Generally, it was observed that 12 cases
of well-differentiated tumors showed weak immu-
nostaining of HIF-1a and VEGF. Only 2 cases
revealed strong reactivity of the studied antigens
and these cases were classified clinically as stage
III and IV with LN metastasis (Figs. 8 and 9)
(Table 5).3.3.2.2. Moderately-differentiated OSCC (grade II, 17
cases)
- Few cases showed localized HIF-1a immunoreac-
tivity either nuclear or cytoplasmic (Fig. 6b), while
most cases of moderately-differentiated OSCC
demonstrated diffuse HIF-1a expression throughout
the entire tumor which was independent of vessel
proximity. Nuclear HIF-1a was predominant than
cytoplasmic staining in 14 cases (82.3%) (Fig. 6c).
Almost all of these cases (16 cases) were clinically
Fig. 6. Moderately-differentiated OSCC: (a) Malignant epithelial nests invading the connective tissue (H&E, 200). (b) Localized cytoplasmic
HIF-1a expression (ABC, 200). (c) Diffuse strong nuclear HIF-1a expression of tumor cells of OSCC (ABC, 200). (d) The same previous field
of OSCC shows strong reactivity of VEGF of both tumor and stromal cells (ABC, 200). (e) Weak nuclear and cytoplasmic HIF-1a immu-
nostaining of OSCC cells (ABC, 200). (f) Weak VEGF expression of both tumor and stromal cells in the same previous case (ABC, 200). (g)
HIF-1a immunoreactivity of endothelial cells (ECs) of the tumor stroma (ABC, 400). (h) Strong VEGF staining of the stromal inflammatory and
vascular ECs (ABC, 400).
S7H. El-Sayed Mohammed Youssef et al. / Tanta Dental Journal 12 (2015) S1eS14classified as stage III and IV. Endothelial HIF-1a
immunostaining was also seen in 12 cases (70%)
(Fig. 6g). VEGF reactivity appeared mostly as
diffuse moderate brown cytoplasmic staining in the
malignant cells with higher intensity at the outer
cell layers (Fig. 6d and f).
- By analyzing the expression level of HIF-1a in
moderately-differentiated OSCC, it was found that10 cases demonstrated high scores of immunore-
activity (5 cases were moderate and 5 cases were
strong) (Figs. 6c and 8), while 6 cases showed
weak HIF-1a immunoreactivity (Figs. 6e and 8).
Only one case was not positive for HIF-1a
expression. On the other hand, VEGF expression
showed high scores of staining in 12 cases (6 were
moderate and 6 cases were strong) (Fig. 6d). The
Fig. 7. Poorly-differentiated OSCC, (a) Individual malignant epithelial cells invading the connective tissue with prominent hyperchromatism and
pleomorphism (H&E, 200), (b) Diffuse strong nuclear and cytoplasmic HIF-1a expression of tumor cells (ABC, 400), (c) Diffuse VEGF
reactivity of malignant cells and stromal cells (ABC, 200), (d) Weak HIF-1a immunostaining in a case classified clinically as stage-I (ABC,
200), (e) Weak VEGF staining in the previous stage-I case (ABC, 400), (f) Strong VEGF immunostaining of stromal fibroblasts at the deep
invasive front where muscles are invaded by malignant cells (Blue arrow) ((ABC, 200).
Table 2
Histopathological grades in relation to the different clinical stages of OSCC.
Clinical stages Histopathological grades Total
Well differentiated Moderately differentiated Poorly differentiated
n (%) n (%) n (%) n (%)
Stage I 6 (46) 5 (38.7) 2 (15.3) 13 (28.9)
Stage II 8 (66.7) 3 (25) 1 (8.3) 12 (26.7)
Stage III 4 (33.3) 5 (41.7) 3 (25) 12 (26.7)
Stage IV 1 (12.5) 4 (50) 3 (37.5) 8 (17.7)
Total 19 (42.2) 17 (37.8) 9 (20) 45 (100)
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VEGF (Figs. 6f and 9) (Table 5).
- VEGF immunostaining was also observed mark-
edly in the stromal fibroblasts, inflammatory cells
and vascular ECs (Fig. 6h).3.3.2.3. Poorly-differentiated OSCC (grade III, 9
cases)
- HIF-1a expression in most cases of poorly-
differentiated OSCC (7 out of 9 cases) appeared
mainly as intense diffuse nuclear reaction of theinvading malignant cells, with or without cyto-
plasmic localization (Fig. 7b). Only one case
showed cytoplasmic HIF-1a reactivity without
nuclear pattern of expression.
- As shown in Table 5, the majority of poorly-
differentiated specimens (7 cases) showed high
HIF-1a and VEGF expressions (moderate and
strong stainings) (Fig. 7b and c). Whereas, only
few cases showed weak expression levels of these
antigens (2 cases out of 9 for both HIF-1a and
VEGF) (Figs. 8 and 9). Interestingly, the cases that
demonstrated weak expression of the studied an-
tigen were classified clinically as stage I and II
Table 4
VEGF expression in relation to the age and site of OSCC cases.
Age range (years) VEGF expression Total
Weak Moderate Strong
n % n % n % n
30e39 4 (100) e e e e 4
40e59 12 (48) 7 (28) 6 (24) 25
60e69 3 (23) 7 (53.8) 2 (15.2) 13
70e74 e e 2 (50) 2 (50) 4
Site of OSCC n % n % n % Total
Tongue 6 (35.3) 6 (35.3) 5 (29.4) 17
Buccal mucosa 4 (40) 4 (40) 2 (20) 10
Gingiva and Alveolar
mucosa
3 (42.9) 3 (42.9) 1 (14.3) 7
Lip 2 (50) 2 (50) e e 4
Palate 2 (50) 1 (25) 1 (25) 4
Floor of the mouth 1 (33.3) 1 (33.3) 1 (33.3) 3
Table 5
HIF-1a and VEGF expressions in clinical stages and histo-pathological gra
Antigen expression Clinical stages
Stage I Stage II Stage III
n % n % n %
HIF-1a Negative 1 7 1 8 e e
Weak 10 8 6 50 4 33
Moderate 2 15 4 34 4 33
Strong e e 1 8 4 34
VEGF Negative e e e e e e
Weak 11 85 5 42 3 25
Moderate 2 15 7 58 4 33
Strong e e e e 5 42
Table 3
Expression of HIF-1a in relation to the age and site of OSCC cases.
Age range (years) HIF-1a expression Total
Negative Weak Moderate Strong
n (%) n (%) n (%) n (%) n
20e39 1 (25) 3 (75) e e e e 4
40e59 e e 12 (48) 8 (32) 5 (20) 25
60e69 1 (8.3) 4 (33.3) 4 (33.3) 3 (25) 12
70e76 e e e e e e 4 (100) 4
Site of OSCC n (%) n %) n (%) n (%) Total
Tongue 1 (5.9) 6 (35.3) 3 (17.6) 7 (41.2) 17
Buccal mucosa e e 6 (60) 3 (30) 1 (10) 10
Gingiva and Alveolar
mucosa
1 (14.3) 2 (28.6) 4 (57.1) e e 7
Lip e e 2 (50) 1 (25) 1 (25) 4
Palate e e 2 (50) 1 (25) 1 (25) 4
Floor of the mouth e e 1 (33.3) e e 2 (66.7) 3
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observed in the stromal cells especially fibroblasts
at the deep invasive front (Fig. 7f). Generally, in all
the studied 45 cases of OSCC HIF-1a and VEGF
expressions showed significant correlation with the
degree of differentiation of OSCC (p ¼ 0.001 for
each antigen) (Table 6). Moreover, HIF-1a
expression was significantly correlated to tumor
cell angiogenesis measured by VEGF reactivity
(p ¼ 0.001) (Table 7).
4. Discussion
OSCC remains one of the most difficult malig-
nancies to control and there has been little improve-
ment in the survival rate over the past 20 years. Despite
many efforts, precise assessment of progression and
behavior of OSCC with a view to predict prognosis
remains an elusive goal.
This study showed that men were more affected
than women; however, the male: female ratio was less
pronounced (1.2:1). Similar trends have been reported
in literature regarding the gender with increasing
incidence in women that has been attributed to
increased participation of women in risk factor be-
haviors such as smoking and alcohol consumption in
recent decades [21,22]. In this study, Tongue was the
most affected site (37.8%) and mostly associated with
metastasis (53.8%). This is supported by previous
studies that showed the same results [23e25] and may
be explained by the rich blood supply and lymphatic
drainage of the tongue.
The present study revealed a non-significant direct
correlation between clinical stages and the degree of
differentiation of OSCC. These results are consistentdes of OSCC.
Histopathological grades
Stage IV Grade I Grade II Grade III
n % n % n % n %
e e 1 5 1 5 e e
e e 12 63 6 35 2 22
1 12 4 21 5 30 2 22
7 88 2 11 5 30 5 56
e e e e e e e e
e e 12 63 5 30 2 22
2 25 5 26 6 35 4 44
6 75 2 11 6 35 3 34
Fig. 9. Analysis of VEGF expression in different histopathological grades of OSCC.
Table 6
Correlation between histopathological grade, HIF-1a and VEGF
expressions.
Variables Histopathological grade
rho p
HIF-1a expression 0.572 0.001*
VEGF expression 0.528 0.001*
Monte Carlo Exact Test: p ¼ 0.001 (*Significant).
Table 7
Correlation between HIF-1a and VEGF expressions in OSCC.
Variables HIF-1a expression
rho p
VEGF expression 0.859 0.001*
Monte Carlo Exact Test: p ¼ 0.001 (*Significant).
Fig. 8. Analysis of HIF-1a expression in different histopathological grades of OSCC.
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same results in OSCC of the tongue with the tumor size
fails to signify any information related to the actual
histological condition of the tumor.Hypoxia is a common characteristic of human solid
tumors, and it can drive malignant cells to undergo
adaptive changes that enable them to survive in
oxygen-depleted regions. It has been suggested that
tumor hypoxia plays an essential role in promoting
chromosome instability, cancer cell invasiveness, and
metastasis. It is associated with aggressive tumor
growth and treatment failure in several human solid
tumors [2,3].
When correlating HIF-1a reactivity with clinical
features of the studied cases regarding the age of the
patients, the correlation was positive. This may be due
to mutations that are more common to occur in older
people. Consequently, these mutations might activate
oncogenes that encourage the expression of many
transcriptional factors such as HIF-1a and their acti-
vation [27].
Angiogenesis is another adaptive response of tumor
cells to hypoxia. VEGF is a multifunctional cytokine
expressed by both tumor and stromal cells. Its angio-
genic effect is based on its ability to induce various
S11H. El-Sayed Mohammed Youssef et al. / Tanta Dental Journal 12 (2015) S1eS14responses by ECs during vascular development,
including cell proliferation, migration, specialization
and survival [28].
In the current study, enhanced VEGF expression
also appeared in old-aged patients than in young pa-
tients. This could be due to the epigenetic changes that
are increasingly recognized as a part of aging as
hypermethylation of p53 genes. This may lead to gene
silencing and suppress its function, thus facilitate
VEGF expression to escape the control of p53 sup-
pressor gene [27,29].
Furthermore, the observed significant correlation
between HIF-1a, clinical stages and LN status of
OSCC in this study was consistent with that reported
by Eckert et al. [30] and Tilakaratne and Nissanka-
Jayasuriya. [31], who found a positive correlation be-
tween HIF-1a, tumor size, recurrences, nodal and
distant metastasis. This may be a result of upregulation
of matrix metalloproteinases (MMPs) in hypoxic
OSCC that are responsible for degradation of the
extracellular matrix (ECM). These findings are indic-
ative that HIF-1a overexpression in OSCC might be
responsible for enhancement of tumor invasion as well
as metastasis, resulting in poor prognosis of OSCC
[32]. Furthermore, Ryu et al. [33], postulated that HIF-
1a accumulation in tumor cells modulates a2-integrin
and fibronectin (invasion-related factors) favoring in-
vasion by enhancement of new cell-ECM attachments
by fibronectin-rich ECM deposition.
Imai et al. [34], also observed downregulation of E-
cadherin expression in OSCC cells under hypoxic
conditions that leads to loss of cellular cohesiveness,
consequently resulting in more invasive and metastatic
potential of tumor cells.
In addition, VEGF expression was also found in this
study to be positively correlated with clinical stage of
OSCC and LN metastasis. Similar results were re-
ported in previous studies in HN cancer and OSCC
[35e37]. This correlation may be attributed to the role
of VEGF as a selective mitogen for vascular ECs that
induce tumor angiogenesis by promoting the differen-
tiation and proliferation of ECs. Then, VEGF guides
the angiogenic sprouts to expand the primary plexus
and vascularize the growing tumor that facilitate tumor
expansion and invasion [38]. Additionally, VEGF was
also reported to induce vasodilatation and increases
vascular permeability. This makes the newly-formed
capillaries more penetrable by tumor cells than
normal vessels, consequently, increasing the risk of
metastasis [39].
The direct correlation between HIF-1a and local
recurrence is supported by the results of Katsuta et al.[40], Schrijvers et al. [41], in esophageal and glottic
laryngeal carcinoma respectively. These results may
reveal the role of HIF-1a in attaining an aggressive
phenotype of the tumor cells that have the ability for
invasion, metastasis and local recurrence.
Histologically, the localized HIF-1a expression
around keratinized and necrotic areas of the tumor or
in regions distal to the nearest blood vessel appeared to
corroborate with the observations of previous studies
[9,42]. This supports the hypothesis that HIF-1a
expression is induced mainly by hypoxia and the
presence of blood vessels in the tumor stroma does not
necessarily ensure that a region of tumor is receiving
appropriate perfusion and oxygenation. This could be
due to the tumor blood flow that may be transiently
compromised in regions where microvessels are
immature, deformed or occluded. Moreover, areas
where cells beyond the diffusion distance of oxygen
from microvessel may be subjected to chronic hypoxia
that strongly induce cells to produce HIF-1a as an
adaptive mechanism to this hypoxia [42,43].
These previous findings are also supported by the
observations of a more recent study by Zhu et al. [44],
who observed that HIF-1a protein and mRNA levels
were hardly detected under normoxic condition, but
were remarkably increased at hypoxic condition
analyzed by using Western blot and quantitative
transcriptase-polymerase chain reaction (RT-PCR).
Furthermore, the diffuse HIF-1a expression
observed in some cases of OSCC irrespective with the
distance from the closest blood vessel, may be
explained by the hypothesis that HIF-1a production is
not only stimulated by hypoxia, but also with other
signals as growth factors as well as the activation of
other oncogenic signal transduction pathways that may
play a role in upregulation of HIF-1a expression in
addition to hypoxia [45].
Additionally, the nuclear expression of HIF-1a was
more predominant and intense in advanced stages and
increased degree of malignancy of OSCC in this study.
These observations were in accordance with previous
studies made by Ogane et al. [46] and Zhu et al. [44],
who evaluated HIF-1a expression in SCC focusing on
the nuclear pattern in comparison to the cytoplasmic
one. They found that nuclear pattern predominance is
considered to be strongly related to the activated status
of HIF-1a as it becomes trans-located to the nucleus to
dimerize with HIF-1b subunit to form HIF-1 molecule
that may control many pathways involved in aggressive
behavior of the tumors [47].
The significant correlation of HIF-1a expression
with the histopathological grade of OSCC in the
S12 H. El-Sayed Mohammed Youssef et al. / Tanta Dental Journal 12 (2015) S1eS14current study is supported by the results of previous
studies that revealed similar findings in OC [7,48]. This
may indicate that HIF-1a upregualtion occurs well in
early carcinogenesis and an essential step before
acquiring invasive phenotype. Emerging experimental
evidence indicates that hypoxic HIF-1a expression
plays important role in the regulation of phenotype and
function of cancer stem cells (CSCs) by inducing the
activation of signature genes of CSCs that enhance
self-renewal capacity and maintenance of undifferen-
tiated state of these cells [49].
In this study, only two cases of OSCC revealed no
positivity of HIF-1a immunoreactivity. At present,
there is no certain explanation for this finding. How-
ever, the prolonged fixation of tissue specimens is
known to substantially compromise antigen detection,
so that failure to stain these cases might be artificial.
Otherwise, this negativity could be also explained that
HIF-1a protein expression in these cases was at levels
below the limits of detection by IHC methodology
[50].
In the present study, VEGF expression was found to
be significantly upregulated with increased malignant
criteria of OSCC, as it was markedly higher in poorly-
differentiated OSCC compared to well-differentiated
cases. However, VEGF reactivity was not positive or
very weak in the normal epithelium. Similar findings
were reported by Macluskey et al. [11], and Shang
et al. [51], who observed a significant increase in
VEGF expression during the transition from normal
oral mucosa through different degrees of dysplasia.
These findings suggest the hypothesis that VEGF is
strongly involved in angiogenesis and it is essential in
the development of OSCC.
In the current study, HIF-1a and VEGF immuno-
reactivities were also observed in the vascular ECs of
the tumor stroma and HIF-1a showed significant cor-
relation with tumor angiogenesis measured by VEGF
staining. These findings were in a line with a previous
study that found that the endothelial HIF-1a mediates
pathway for VEGF expression and deletion of HIF-1a
in ECs disrupts an autocrine loop necessary for hyp-
oxic induction of VEGFR-1 and VEGFR-2 signaling
by preventing the binding of HIF-1 to an enhancer
element located in VEGFR-1 and the post-
trancriptional regulation of VEGFR-2 by HIF-1.
Thus, this will result in decreased endothelial prolif-
eration and tube formation in vitro leading to severely
impaired tumor angiogenesis and reduced tumor
growth in vivo [52].
Accordingly, all the previous observations of this
study shed a light on the importance of TME changes,specifically hypoxia and angiogenesis, in controlling
the behavior of OSCC. This confirms the hypothesis
that the adaptive pathways to hypoxia as HIF-1a and
VEGF expressions and their upregulation may play a
crucial role in tumor angiogenesis, progression and
consequently, controlling the behavior of OSCC.
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